PREHEVBRIO (PF) (hepatitis B virus vaccine recombinant,isoform S,M,L/PF)
HEPATITIS B VACCINE · HEPATITIS B VACCINATION
VBI VACCINES (D
Drug class
Hepatitis B Vaccine
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV). Read more about Hepatitis B Vaccine
24 drugs in this class 6 manufacturers
Drugs in Hepatitis B Vaccine
VAXELIS (diphtheria,pertus(acell),tetanus/hepB/polio/Hib conj-meng/PF)
DIPHTHERIA TOXOID · DIPHTHERIA, PERTUSSIS, TETANUS, HEPATITIS B AND POLIO VACCINATION ·+1
MSP VACCINE COM
ENGERIX-B ADULT (hepatitis B virus vaccine recombinant/PF)
HEPATITIS B VACCINE · HEPATITIS B VACCINATION
A-S MEDICATION
VAXELIS (diphtheria,pertus(acell),tetanus/hepB/polio/Hib conj-meng/PF)
DIPHTHERIA TOXOID · DIPHTHERIA, PERTUSSIS, TETANUS, HEPATITIS B AND POLIO VACCINATION ·+1
A-S MEDICATION
HEPLISAV-B (hepatitis B vaccine recombinant/vaccine adjuvant CpG 1018/PF)
HEPATITIS B VACCINE · HEPATITIS B VACCINATION
A-S MEDICATION
PEDIARIX (hep B virus,rcmb/dipth,pertus(acell),tet,polio vaccine/PF)
DIPHTHERIA TOXOID · DIPHTHERIA, PERTUSSIS, TETANUS, HEPATITIS B AND POLIO VACCINATION
A-S MEDICATION
Filter & compare in the drug finder →
Opens the drug finder with Hepatitis B Vaccine preselected. Add indication or manufacturer filters there.
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV).
These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus.
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures.
By preventing acute HBV infection, these vaccines effectively avert the progression to chronic hepatitis B, cirrhosis, and hepatocellular carcinoma.
-
fda.gov
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV) These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus
-
nih.gov
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV) These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus By preventing acute HBV infection, these vaccines effectively avert the progressio...
-
cdc.gov
These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus
-
fda.gov
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures
-
cdc.gov
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures
-
fda.gov
By preventing acute HBV infection, these vaccines effectively avert the progression to chronic hepatitis B, cirrhosis, and hepatocellular carcinoma
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.